Synergistic Ophthalmic Diagnostic Systems

Publication ID: 24-11857255_0003_PTD
Published: November 07, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Ophthalmic Diagnostic Systems,” Published Technical Disclosure No. 24-11857255_0003_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857255_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,255.

Summary of the Inventive Concept

This inventive concept integrates an ophthalmic apparatus with cutting-edge technologies such as AI, IoT, blockchain, and new materials to create a more powerful and efficient diagnostic system for ophthalmic diseases.

Background and Problem Solved

The original ophthalmic apparatus patent has limitations in terms of data analysis, storage, and sharing. This new inventive concept addresses these limitations by incorporating advanced technologies to enhance diagnostic accuracy, security, and accessibility.

Detailed Description of the Inventive Concept

The synergistic system combines an ophthalmic apparatus with an artificial intelligence module for advanced image analysis and diagnostic recommendations. It also integrates with a cloud-based server for secure data storage and sharing, utilizing blockchain technology for secure data management. Furthermore, the system can be connected to an IoT network for remote monitoring and analysis. Additionally, the system can generate 3D models of the target part for personalized treatment planning.

Novelty and Inventive Step

The new claims introduce novel combinations of the ophthalmic apparatus with AI, IoT, blockchain, and new materials, providing a significant improvement over the original patent. The inventive step lies in the synergistic integration of these technologies to create a more powerful and efficient diagnostic system.

Alternative Embodiments and Variations

Alternative embodiments may include integrating the ophthalmic apparatus with other AI algorithms, using different blockchain protocols, or incorporating new materials for improved image capture. Variations may include adapting the system for use in different medical specialties or developing portable versions for remote diagnosis.

Potential Commercial Applications and Market

The synergistic ophthalmic diagnostic system has significant commercial potential in the healthcare industry, particularly in ophthalmology and optometry. It can also be applied in telemedicine, medical research, and pharmaceutical industries, offering a competitive advantage in terms of diagnostic accuracy and efficiency.

CPC Classifications

SectionClassGroup
A A61 A61B3/0025
A A61 A61B3/0041
A A61 A61B3/102

Original Patent Information

Patent NumberUS 11,857,255
TitleOphthalmic apparatus
Assignee(s)Tomey Corporation